Artal International Management S.A. (CIK 1522131) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-17). Recent activity: Sell CAVA (3.0M shares), Buy LXRX (20.4M shares), Buy LXRX (41,290 shares), Buy LXRX (18.6M shares), Buy LXRX (3.8M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | CAVA GROUP, INC. (CAVA) | Director | Sell | 3.0M | $270.9M |
| 2026-05-08 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 20.4M | $0 |
| 2026-02-19 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 41,290 | $0 |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 18.6M | $24.1M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 3.8M | $5.0M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 1.5M | $2.0M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 367,145 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17